Syon Capital LLC Buys 9,530 Shares of SPDR S&P Biotech ETF $XBI

Syon Capital LLC increased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 67.9% during the second quarter, HoldingsChannel.com reports. The fund owned 23,562 shares of the exchange traded fund’s stock after purchasing an additional 9,530 shares during the period. Syon Capital LLC’s holdings in SPDR S&P Biotech ETF were worth $3,729,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the stock. Avoro Capital Advisors LLC bought a new stake in SPDR S&P Biotech ETF during the fourth quarter worth approximately $256,053,000. Bank of America Corp DE raised its position in shares of SPDR S&P Biotech ETF by 13.3% in the first quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock valued at $1,854,388,000 after purchasing an additional 1,700,851 shares during the period. Wells Fargo & Company MN lifted its stake in shares of SPDR S&P Biotech ETF by 75.7% in the fourth quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock worth $434,835,000 after buying an additional 1,536,122 shares during the last quarter. OMERS ADMINISTRATION Corp lifted its stake in shares of SPDR S&P Biotech ETF by 42,425.2% in the fourth quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock worth $145,147,000 after buying an additional 1,187,907 shares during the last quarter. Finally, Morgan Stanley boosted its holdings in shares of SPDR S&P Biotech ETF by 8.3% during the 4th quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock worth $1,401,181,000 after buying an additional 882,718 shares during the period.

SPDR S&P Biotech ETF Trading Down 0.6%

NYSEARCA:XBI opened at $164.38 on Friday. SPDR S&P Biotech ETF has a 1 year low of $92.49 and a 1 year high of $169.89. The firm’s fifty day simple moving average is $158.01 and its 200 day simple moving average is $140.34. The firm has a market capitalization of $10.73 billion, a PE ratio of 11.47 and a beta of 0.84.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.